Crystal Diagnostics (CDx) has developed a novel liquid crystal technology and the necessary related equipment to detect pathogens in food and water quickly and reliably. This technology platform will have multiple applications in food, veterinary, medical, water safety, and other sectors.

Cdx has exclusive world wide rights to patents for liquid crystal technology owned by Kent State University and Northeast Ohio Medical University. The company has been engaged in development and commercialization of the technology since 2006.

The History

Crystal Diagnostics™ was founded in 2006 and is the first to use liquid crystals as a biosensor.  This technology had been patented by Kent State University and the Northeast Ohio Medical University.  Earlier, the technology had been proven via a substantial grant from the U.S. Army in 2003 related to water safety concerns for U.S. troops.

Since 2006, the Company has designed and built the system -- namely, a reader and a five-cell disposable cassette -- as well as developed the software necessary to move the technology from the laboratory to commercial applications.  The unique testing process detects multiple pathogens (for example, multiple E. coli strains and salmonella) in a single test, rapidly and reliably.  The Company is concentrating initially on food safety testing.

Crystal Diagnostics, Ltd. maintains a software and engineering office in Broomfield, Colorado and bioscience laboratories at the Northeast Ohio Medical University in Rootstown, Ohio, and a manufacturing plant in Kent State University's Centennial Research Park in Kent, Ohio.

In Association With: